Cartesian Therapeutics Inc

자세한 내용은 Cartesian Therapeutics Inc 회사

Cartesian Therapeutics, Inc. is a clinical-stage company. The Company is engaged in developing messenger ribonucleic acids (mRNA) cell therapies for the treatment of autoimmune diseases. It is leveraging its proprietary technology and manufacturing platform, RNA Armory, to develop mRNA cell therapies for autoimmune diseases. Its lead asset e, Descartes-08, is an autologous mRNA chimeric antigen receptor T-cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), that the Company is developing for the treatment of autoimmune diseases. Descartes-08 is in Phase II clinical development. Descartes-15 is a next-generation, autologous anti-BCMA mRNA CAR-T. Using its proprietary technology and manufacturing platform, it designed Descartes-15 to be more resistant than Descartes-08 to recycling of the CAR upon multiple antigen exposures. It is developing Descartes-33 to deliver a combination of therapeutic proteins that target key drivers in the pathogenesis of autoimmunity.

회사 정보

종목 코드 RNAC

회사 이름Cartesian Therapeutics Inc

상장일Jun 22, 2016

CEODr. Carsten Brunn, Ph.D.

직원 수66

유형Ordinary Share

회계 연도 종료Jun 22

주소7495 New Horizon Way

도시FREDERICK

증권 거래소NASDAQ Global Market Consolidated

국가United States of America

우편 번호21703

전화13013488698

웹사이트https://www.cartesiantherapeutics.com/

종목 코드 RNAC

상장일Jun 22, 2016

CEODr. Carsten Brunn, Ph.D.

회사 임원

이름

이름/직위

직위

주식 보유

변동

Dr. Murat Kalayoglu, M.D., Ph.D.

Independent Director

502.42K

-1.74%

Dr. Emily English, Ph.D.

Chief Operations Officer

36.95K

+25.46%

Dr. Carsten Brunn, Ph.D.

President, Chief Executive Officer, Director

30.24K

-38.23%

Dr. Milos Miljkovic, M.D.

Chief Medical Officer

17.12K

--

Mr. Blaine Davis

Chief Financial Officer

12.21K

-87.12%

Mr. Patrick J. (Pat) Zenner

Independent Director

3.82K

-14.03%

Dr. Kemal Malik

Independent Director

--

-100.00%

Dr. Michael S. Singer, M.D., Ph.D.

Independent Director

--

Mr. Timothy C. (Tim) Barabe

Independent Director

--

Dr. Nishan M. de Silva, M.D.

Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Dr. Murat Kalayoglu, M.D., Ph.D.

Independent Director

502.42K

-1.74%

Dr. Emily English, Ph.D.

Chief Operations Officer

36.95K

+25.46%

Dr. Carsten Brunn, Ph.D.

President, Chief Executive Officer, Director

30.24K

-38.23%

Dr. Milos Miljkovic, M.D.

Chief Medical Officer

17.12K

--

Mr. Blaine Davis

Chief Financial Officer

12.21K

-87.12%

Mr. Patrick J. (Pat) Zenner

Independent Director

3.82K

-14.03%

수익 분석

데이터 없음

데이터 없음

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Wed, Jul 23

주주

주주 유형

주주

비율

Springer Timothy A

33.28%

Seven One Eight Three Four Irrevocable Trust

17.55%

Fidelity Management & Research Company LLC

9.02%

MPM BioImpact LLC

3.05%

Singer (Michael S.)

2.72%

Other

34.38%

주주

비율

Springer Timothy A

33.28%

Seven One Eight Three Four Irrevocable Trust

17.55%

Fidelity Management & Research Company LLC

9.02%

MPM BioImpact LLC

3.05%

Singer (Michael S.)

2.72%

Other

34.38%

주주 유형

주주

비율

Individual Investor

39.94%

Corporation

20.08%

Investment Advisor

18.12%

Investment Advisor/Hedge Fund

5.70%

Hedge Fund

1.47%

Research Firm

0.19%

Insurance Company

0.10%

Bank and Trust

0.10%

Pension Fund

0.03%

Other

14.26%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

206

22.28M

85.84%

-1.26M

2025Q1

226

22.94M

90.08%

+138.68K

2024Q4

230

22.26M

88.90%

-105.22K

2024Q3

229

20.22M

92.77%

+6.58M

2024Q2

235

14.41M

85.20%

+9.02M

2024Q1

233

3.74M

346.71%

-1.42M

2023Q4

240

3.82M

71.00%

-922.87K

2023Q3

251

3.63M

70.60%

-1.17M

2023Q2

261

3.72M

72.70%

-649.68K

2023Q1

272

3.43M

67.38%

-196.84K

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Springer Timothy A

8.64M

33.28%

+22.36K

+0.26%

Apr 14, 2025

Seven One Eight Three Four Irrevocable Trust

4.56M

17.55%

--

Apr 14, 2025

Fidelity Management & Research Company LLC

2.34M

9.02%

-83.30K

-3.44%

Mar 31, 2025

MPM BioImpact LLC

790.78K

3.05%

+69.64K

+9.66%

Mar 31, 2025

Singer (Michael S.)

707.06K

2.72%

-623.00

-0.09%

Apr 14, 2025

TAS Partners, L.L.C.

656.51K

2.53%

+126.72K

+23.92%

Apr 14, 2025

BlackRock Institutional Trust Company, N.A.

608.03K

2.34%

+1.49K

+0.25%

Mar 31, 2025

Invus Public Equities Advisors, LLC

563.27K

2.17%

-8.96K

-1.57%

Mar 31, 2025

The Vanguard Group, Inc.

503.54K

1.94%

+74.06K

+17.24%

Mar 31, 2025

Kalayoglu (Murat)

502.42K

1.94%

-8.88K

-1.74%

Apr 14, 2025

12.260USD

Cartesian Therapeutics Inc

12.260

개요

회사

금융